Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Stat3/5 Signaling Biosignature in Hematopoietic Stem/Progenitor Cells Predicts Response and Outcome in Myelodysplastic Syndrome Patients Treated with Azacitidine.
Miltiades P, Lamprianidou E, Vassilakopoulos TP, Papageorgiou SG, Galanopoulos AG, Kontos CK, Adamopoulos PG, Nakou E, Vakalopoulou S, Garypidou V, Papaioannou M, Hatjiharissi E, Papadaki HA, Spanoudakis E, Pappa V, Scorilas A, Tsatalas C, Kotsianidis I; Hellenic MDS Study Group. Miltiades P, et al. Among authors: spanoudakis e. Clin Cancer Res. 2016 Apr 15;22(8):1958-68. doi: 10.1158/1078-0432.CCR-15-1288. Epub 2015 Dec 23. Clin Cancer Res. 2016. PMID: 26700206
Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine.
Miltiades P, Lamprianidou E, Vassilakopoulos TP, Papageorgiou SG, Galanopoulos AG, Vakalopoulou S, Garypidou V, Papaioannou M, Hadjiharissi E, Pappa V, Papadaki HA, Spanoudakis E, Tsatalas K, Kotsianidis I. Miltiades P, et al. Among authors: spanoudakis e. Blood Cancer J. 2014 Feb 28;4(2):e187. doi: 10.1038/bcj.2014.9. Blood Cancer J. 2014. PMID: 24583533 Free PMC article. No abstract available.
Proteolytic matrix metallopeptidases and inhibitors in BCR-ABL1-negative myeloproliferative neoplasms: correlation with JAK2 mutation status.
Vadikolia CM, Tsatalas C, Anagnostopoulos K, Trypsianis G, Pantelidou D, Bazdiara I, Anastasiadis A, Spanoudakis E, Kotsianidis I, Margaritis D, Kortsaris A, Bourikas G. Vadikolia CM, et al. Among authors: spanoudakis e. Acta Haematol. 2011;126(1):54-62. doi: 10.1159/000324436. Epub 2011 Apr 7. Acta Haematol. 2011. PMID: 21474922
Eluate testing with monospecific antisera unmasks multiple immunoglobulin classes and identifies frequent IgA involvement in severe autoimmune hemolytic anemia.
Bezirgiannidou Z, Kontekaki E, Christoforidou A, Zisaki S, Chouchos K, Papamichos S, Vrachiolias G, Papoutselis M, Spanoudakis E, Martinis G, Kotsianidis I, Mantadakis E. Bezirgiannidou Z, et al. Among authors: spanoudakis e. Transfus Apher Sci. 2018 Jun;57(3):384-387. doi: 10.1016/j.transci.2018.04.020. Epub 2018 Apr 22. Transfus Apher Sci. 2018. PMID: 29716828 No abstract available.
Hydroxyurea and anagrelide combination therapy in patients with chronic myeloproliferative diseases resistant or intolerant to monotherapy.
Christoforidou A, Pantelidou D, Anastasiadis A, Goutzouvelidis A, Margaritis D, Kotsianidis I, Spanoudakis E, Kaloutsi V, Bourikas G, Tsatalas C. Christoforidou A, et al. Among authors: spanoudakis e. Acta Haematol. 2008;120(4):195-8. doi: 10.1159/000189381. Epub 2009 Jan 8. Acta Haematol. 2008. PMID: 19129692 No abstract available.
Onionskin-like histiocytes in an HIV late presenter.
Petrakis V, Panagopoulos P, Vrachiolias G, Spanoudakis E, Papazoglou D, Kotsianidis I, Liapis K. Petrakis V, et al. Among authors: spanoudakis e. QJM. 2022 May 10;115(5):312-313. doi: 10.1093/qjmed/hcac082. QJM. 2022. PMID: 35325246 No abstract available.
74 results